Company News

News

Company News

Home/News

2024-08-27

Great Bay Bio Listed on Forbes Asia 100 to Watch 2024

Great Bay Bio was successfully selected for Forbes Asia 100 to Watch 2024 List.

2024-08-22

Overview of Biotechnology Development in Hong Kong

Hong Kong, long renowned as one of the world's most prosperous financial centers, has now added another title - &nb

2024-08-15

AlfaCell: Obtain High-Yield & Stable Cell Lines in 1.5 Months

Cell line development is a cornerstone in the development of macromolecule drugs. Traditional methods involve transfec

2024-07-22

AlfaDAX丨The Prediction Accuracy of Predicting Aggregation and Precipitation of 28 Innovative Molecules Reached 89.3%

AlfaDAX丨The Prediction Accuracy of Aggregation and Precipitation of 28 Innovative Molecules Reached 89.3% AlfaD

2024-06-25

Great Bay Bio Obtained Authentication of ISO 9001:2015 - Quality Management Systems

Recently, Great Bay Bio’s wholly-owned subsidiary (Shenzhen Taili Biotechnology) has been assessed and certified as me

2024-06-18

Online System for Molecule Assessment and Optimization

The online system of Bio-product Molecule Assessment and Optimization Platform Platform (#AlfaDAX) was launched. The A

2024-05-16

Uni-Bio – GBB – Pebble Accelerator Signed Agreement to Co-Develop Novel Weight-loss Drugs

Hong Kong May 16, 2024 Great Bay Bio (hereinafter referred to as “GBB”), Pebble Accelerator (a subsidiary of

2024-02-24

Great Bay Bio’s 2024 strategy conference was successfully held

龙腾盛世，万物争春。2月24日（元宵佳节），大湾生物隆重举办2024年战略发布会暨开工仪式，全体同仁齐聚一堂，共赴新征程。 2024年战略发布会 本年度战略发布会以“钢铁计划”为主题，旨在打造技术铁军
Message